EU-India Call "Next Generation Influenza Vaccine to protect citizens worldwide"

The Department of Biotechnology (DBT), Government of India and the Delegation of the European Union to India are pleased to announce the EU-India call on Next Generation Influenza Vaccine. The European Commission (EC) through the EU funding programme for research and innovation 'Horizon 2020' has committed EUR 15 million and the Department of Biotechnology (DBT), Government of India, agreed to match that amount. In total, funding of EUR 30 million will thus be available.

Information and project preparation events will be organised in four cities (New Delhi, Hyderabad, Bangalore and Pune) in India. These events target potential applicants to the EU-India call on Next Generation Influenza Vaccine for joint project proposals. It will offer an exceptional opportunity to all stakeholders from lab to market: research, pre-clinical trials and vaccine developers from Europe and India.


These networking events will help you to build your consortium for the EU-India call on next generation influenza vaccine, which will be open until 16 April 2019. Don’t miss this opportunity!


This call aims at further advancing the next generation influenza vaccine candidate(s) with improved efficacy and safety, duration of immunity, and reactivity against an increased breadth of influenza strains. Project proposal should make use of new and multidisciplinary knowledge.

Please see attachments for events schedule and more information on the call.